Find all the latest information
, arranged by types, translocations, and mutations.
Listed below are recently updated categories.
Influence of rate of neutrophil recovery on the incidence of GvHD
In a retrospective study, recently published in Transplant International, Takashi Nagayama and colleagues evaluated the influence of...
Phase II results of natalizumab plus steroids for gastrointestinal GvHD
Natasha Kekre and colleagues conducted a phase II clinical trial to investigate the safety and efficacy of an antibody targeting...
Regenerative medicine advanced therapy and orphan drug designation given to ORCA-T
The U.S. Food and Drug Administration (FDA) has granted both orphan drug designation and regenerative medicine...
Establishing the optimal co-receptor signaling domain for chimeric antigen receptor Treg cell therapy
In this study, published in Science Translational Medicine by Nicholas Dawson and colleagues, the...
The impact of JAK inhibitor use on HSCT outcome in patients with MPN
Barabanshikova and colleagues analyzed outcomes of patients with MPN undergoing allo-HSCT with or without prior JAK inhibitor...
KD025 for chronic GvHD: an update
During the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) two posters were presented by Madan Jagasia on KD025 (belumosudil).
Acute graft-versus-host disease
Late acute GvHD
Chronic graft-versus-host disease
Lower GI cGvHD
Upper GI cGvHD
Bone marrow GvHD